http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1472473-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 |
| filingDate | 1974-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1472473-A |
| titleOfInvention | Crystalline prostanoic acid esters |
| abstract | 1472473 Esters of prostaglandins SCHERING AG 29 April 1974 [3 May 1973] 18672/74 Heading C2C Novel esters of prostaglandins in which the ester residue has the formula -CH 2 -X-Y, where X is a direct bond, -CO- or -COO- and Y is substituted phenyl, are prepared by reacting a prostaglandin in the presence of an agent capable of splitting off a hydrogen halide with a compound of formula Hal-CH 2 -X-Y, where Hal is a halogen atom. The esters may be converted to the acids by known methods. Pharmaceutical compositions comprise one of the above novel esters together with a pharmaceutical carrier. The compositions have spasmolytic, bronchodilatory, anti-arryhthmic, hypotensive and diuretic activity. |
| priorityDate | 1973-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.